TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio-Nord AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,025
|
995
|
851 |
| Financial expenses |
39
|
70
|
17 |
| Earnings before taxes |
-19
|
60
|
5 |
| EBITDA |
19
|
130
|
22 |
| Total assets |
1,344
|
660
|
1,320 |
| Current assets |
1,344
|
660
|
1,320 |
| Current liabilities |
1,278
|
568
|
1,259 |
| Equity capital |
45
|
73
|
43 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
3.3%
|
11.1%
|
3.3% |
| Turnover per employee |
342
|
332
|
284 |
| Profit as a percentage of turnover |
-1.9%
|
6.0%
|
0.6% |
| Return on assets (ROA) |
1.5%
|
19.7%
|
1.7% |
| Current ratio |
105.2%
|
116.2%
|
104.8% |
| Return on equity (ROE) |
-42.2%
|
82.2%
|
11.6% |
| Change turnover |
63
|
140
|
121 |
| Change turnover % |
7%
|
16%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.